Close
  Indian J Med Microbiol
 

Figure 1: Kaplan-Meier analysis of BCR-free survival categorized by PSAD quartiles in patients with IRPCa; Pairwise analysis, significant between PSAD < 0.19 versus 0.27 ≤ PSAD < 0.38 (P = 0.025), and between PSAD < 0.19 versus PSAD ≥ 0.38 (P < 0.001). BCR: biochemical recurrence; IRPCa: intermediate-risk prostate cancer.

Figure 1: Kaplan-Meier analysis of BCR-free survival categorized by PSAD quartiles in patients with IRPCa; Pairwise analysis, significant between PSAD < 0.19 versus 0.27 ≤ PSAD < 0.38 (<i>P</i> = 0.025), and between PSAD < 0.19 versus PSAD ≥ 0.38 (<i>P</i> < 0.001). BCR: biochemical recurrence; IRPCa: intermediate-risk prostate cancer.